Acceleron Pharma
Why Robinhood?
You can watch XLRN and buy or sell other stocks, ETFs, and their options commission-free!About XLRN
Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension.
XLRN Key Statistics
Stock Snapshot
The current Acceleron Pharma(XLRN) stock price is $178.75, with a market capitalization of 10.93B. The stock trades at a price-to-earnings (P/E) ratio of -42.53.
During the trading day, Acceleron Pharma(XLRN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.94M.
The stock's 52-week range extends from a low of $111.29 to a high of $189.99.
The stock's 52-week range extends from a low of $111.29 to a high of $189.99.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.